美國
US 12,702,739 B1
Device and method for administering an anti cancer substance
US 12,702,739 B1 是美國專利商標局（USPTO）的核准專利，日期 2026-08-11。申請人：Individual。PDF 可在本頁下載，未登入每天最多 5 篇。
- 申請人
- Individual
- 發明人
- Brian J. Leberthon
- 公開日
- 2026-08-11
- 申請日
- 2021-05-13
- 文件種類
- B1 核准公告
- 也寫作
- US 12,702,739 B1 · US12702739 · 12702739
摘要
An anti-cancer substance is administered via the patient's blood ex vivo and in line by establishing a connection between the patient and a device having a chamber containing the anti-cancer substance. The patient's blood in the chamber and the anti-cancer substance interact so that immune cells in the blood (1) are activated to produce an immune response in the patient, or (2) are pre-armed by attaching to the cells antibodies, or (3) both. After activating or pre-arming the cells, the patient's treated blood is returned to the patient.…
這裡只列摘要開頭，完整內容在 PDF 裡。
不用登入，每天可下載 5 篇（今天還剩 5 篇）。批次下載與 OA 引證整理需免費註冊。
專利局網站： 美國專利商標局（USPTO）